Teladoc Non Currrent Assets Other from 2010 to 2025
| TDOC Stock | USD 8.09 0.47 5.49% |
Non Currrent Assets Other | First Reported 2014-03-31 | Previous Quarter 77.9 M | Current Value 81.5 M | Quarterly Volatility 80 M |
Check Teladoc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Teladoc's main balance sheet or income statement drivers, such as Depreciation And Amortization of 402 M, Interest Expense of 25.2 M or Selling General Administrative of 256.2 M, as well as many indicators such as Price To Sales Ratio of 0.57, Dividend Yield of 0.0 or PTB Ratio of 0.99. Teladoc financial statements analysis is a perfect complement when working with Teladoc Valuation or Volatility modules.
Teladoc | Non Currrent Assets Other |
Latest Teladoc's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Teladoc over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Teladoc's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Teladoc's overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
Teladoc Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | 21,568,025 | |
| Geometric Mean | 2,156,433 | |
| Coefficient Of Variation | 152.03 | |
| Mean Deviation | 26,197,038 | |
| Median | 1,401,000 | |
| Standard Deviation | 32,789,563 | |
| Sample Variance | 1075.2T | |
| Range | 85.5M | |
| R-Value | 0.83 | |
| Mean Square Error | 349T | |
| R-Squared | 0.70 | |
| Significance | 0.000057 | |
| Slope | 5,750,171 | |
| Total Sum of Squares | 16127.3T |
Teladoc Non Currrent Assets Other History
About Teladoc Financial Statements
Teladoc stakeholders use historical fundamental indicators, such as Teladoc's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Although Teladoc investors may analyze each financial statement separately, they are all interrelated. For example, changes in Teladoc's assets and liabilities are reflected in the revenues and expenses on Teladoc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Teladoc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 81.5 M | 85.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Teladoc Correlation against competitors. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.87) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.